Xiaoyan Pan

SARS-CoV-2 ORF9b inhibits RIG-I-MAVS antiviral signaling by interrupting K63-linked ubiquitination of NEMO

Jing Wu, Yuheng Shi, Xiaoyan Pan et al. · Cell Reports · 2021 · 256 citations · Full text

Inflammatory Lung Disease, Lung Inflammation, Innate Immune System +21

SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target

Bingqing Xia, Xu-Rui Shen, Yang He et al. · Cell Research · 2021 · 185 citations · Full text

High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors

Yao Zhao, Xiaoyu Du, Yinkai Duan et al. · Protein & Cell · 2021 · 152 citations · Full text

Immunoglobulin fragment F(ab’)2 against RBD potently neutralizes SARS-CoV-2 in vitro

Xiaoyan Pan, Pengfei Zhou, Tiejiong Fan et al. · Antiviral Research · 2020 · 62 citations · Full text

Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH

Liang Tao, Xinquan Yang, Chaodong Ge et al. · Cell Metabolism · 2024 · 62 citations · Full text

Iron Metabolism, Immunology, Pathology +25